14-94496495-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001382267.1(SERPINA12):āc.783A>Gā(p.Glu261=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00187 in 1,614,122 control chromosomes in the GnomAD database, including 56 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.0099 ( 31 hom., cov: 32)
Exomes š: 0.0010 ( 25 hom. )
Consequence
SERPINA12
NM_001382267.1 synonymous
NM_001382267.1 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0340
Genes affected
SERPINA12 (HGNC:18359): (serpin family A member 12) Predicted to enable serine-type endopeptidase inhibitor activity. Predicted to be involved in negative regulation of endopeptidase activity. Predicted to act upstream of or within negative regulation of gluconeogenesis; positive regulation of signal transduction; and regulation of lipid metabolic process. Predicted to be located in plasma membrane. Predicted to be active in extracellular space. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BP6
Variant 14-94496495-T-C is Benign according to our data. Variant chr14-94496495-T-C is described in ClinVar as [Benign]. Clinvar id is 786624.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.034 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00994 (1514/152270) while in subpopulation AFR AF= 0.0347 (1440/41550). AF 95% confidence interval is 0.0332. There are 31 homozygotes in gnomad4. There are 722 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 31 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SERPINA12 | NM_001382267.1 | c.783A>G | p.Glu261= | synonymous_variant | 3/5 | ENST00000677451.1 | |
SERPINA12 | NM_001304461.2 | c.783A>G | p.Glu261= | synonymous_variant | 3/5 | ||
SERPINA12 | NM_173850.4 | c.783A>G | p.Glu261= | synonymous_variant | 4/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SERPINA12 | ENST00000677451.1 | c.783A>G | p.Glu261= | synonymous_variant | 3/5 | NM_001382267.1 | P1 | ||
SERPINA12 | ENST00000341228.2 | c.783A>G | p.Glu261= | synonymous_variant | 4/6 | 1 | P1 | ||
SERPINA12 | ENST00000556881.5 | c.783A>G | p.Glu261= | synonymous_variant | 3/5 | 1 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00993 AC: 1511AN: 152152Hom.: 31 Cov.: 32
GnomAD3 genomes
AF:
AC:
1511
AN:
152152
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00266 AC: 669AN: 251372Hom.: 16 AF XY: 0.00194 AC XY: 263AN XY: 135852
GnomAD3 exomes
AF:
AC:
669
AN:
251372
Hom.:
AF XY:
AC XY:
263
AN XY:
135852
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00103 AC: 1507AN: 1461852Hom.: 25 Cov.: 32 AF XY: 0.000868 AC XY: 631AN XY: 727226
GnomAD4 exome
AF:
AC:
1507
AN:
1461852
Hom.:
Cov.:
32
AF XY:
AC XY:
631
AN XY:
727226
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00994 AC: 1514AN: 152270Hom.: 31 Cov.: 32 AF XY: 0.00970 AC XY: 722AN XY: 74450
GnomAD4 genome
AF:
AC:
1514
AN:
152270
Hom.:
Cov.:
32
AF XY:
AC XY:
722
AN XY:
74450
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
7
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 14, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at